Boris Bienvenu
University of Caen Lower Normandy
151 Papers
269 Citations
Boris Bienvenu is an academic researcher from University of Caen Lower Normandy. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 37, co-authored 136 publications. Previous affiliations of Boris Bienvenu include Centre Hospitalier Universitaire de Grenoble & Paris Descartes University.
Chat about Author
Papers
Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort
Cloé Comarmond,Christian Pagnoux,Mehdi Khellaf,Jean-François Cordier,Mohamed Hamidou,Jean-François Viallard,François Maurier,Stéphane Jouneau,Boris Bienvenu,Xavier Puéchal,Olivier Aumaître,Guillaume Le Guenno,Alain Le Quellec,Ramiro Cevallos,Olivier Fain,Bertrand Godeau,Raphaèle Seror,Bertrand Dunogué,Alfred Mahr,Philippe Guilpain,Pascal Cohen,Achille Aouba,Luc Mouthon,Loïc Guillevin +23 more
TL;DR: Although EGPA relapses remain frequent, mortality has declined, at least since 1996, and multivariable analysis identified cardiomyopathy, older age, and diagnosis during or prior to 1996 as independent risk factors for death and lower eosinophil count at diagnosis as predictive of relapse.
839
Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database
Christian Pagnoux,Raphaèle Seror,Corneliu Henegar,Alfred Mahr,Pascal Cohen,Véronique Le Guern,Boris Bienvenu,Luc Mouthon,Loïc Guillevin +8 more
TL;DR: It is indicated that the rate of mortality from polyarteritis nodosa remains high, especially for the elderly, and relapses do occur, particularly in patients with non-HBV-related PAN with cutaneous manifestations.
531
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis.
Leandro Ladislau,Leandro Ladislau,Xavier Suárez-Calvet,Xavier Suárez-Calvet,Ségolène Toquet,Océane Landon-Cardinal,D. Amelin,Marine Depp,Mathieu P Rodero,Denisa Hathazi,Darragh Duffy,Vincent Bondet,C. Preusse,Boris Bienvenu,Flore Rozenberg,Andreas Roos,Andreas Roos,Claudia F. Benjamim,Eduard Gallardo,Isabel Illa,Vincent Mouly,Werner Stenzel,Gillian Butler-Browne,Olivier Benveniste,Yves Allenbach +24 more
TL;DR: JAK inhibition is proposed as a mechanism-based treatment for dermatomyositis and a finding that is relevant for the design of future clinical trials targeting dermatomyposis is relevant.
213
Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis
Florent L. Besson,Jean-Jacques Parienti,Boris Bienvenu,John O. Prior,Sylvie Costo,Gérard Bouvard,Denis Agostini +6 more
TL;DR: Overall valuable diagnostic performances for FDG PET against reference criteria are found and standardized FDG uptake criteria are needed to optimize these diagnostic performances.
201
Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA).
Boris Bienvenu,K.H. Ly,Marc Lambert,Christian Agard,Marc André,Ygal Benhamou,Bernard Bonnotte,H. De Boysson,Olivier Espitia,G. Fau,Anne-Laure Fauchais,Françoise Galateau-Salle,Julien Haroche,E. Héron,F.X. Lapébie,Eric Liozon,L.B. Luong Nguyen,J. Magnant,Alain Manrique,M. Matt,M. de Menthon,Luc Mouthon,Xavier Puéchal,Grégory Pugnet,Thomas Quemeneur,Alexis Régent,David Saadoun,Maxime Samson,Damien Sène,P. Smets,Cécile Yelnik,Laurent Sailler,Alfred Mahr +32 more
TL;DR: The recommendations, which will be updated regularly, are intended to guide and harmonize the standards of GCA management.
190